EVERSANA's integrated solutions are rooted in the patient experience and span all stages of the product life cycle to deliver long-term, sustainable value for patients, prescribers, channel partners, and payers.
FREMONT, CA: EVERSANA, the pioneer of next-generation commercial services to the global life sciences industry, unveiled partnerships with comprehensive data and infrastructure companies, including Symphony Health and Compile, to create the industry's first single, streamlined claims, formulary, and physician dataset. The comprehensive, real-time view of the full healthcare system will drive EVERSANA's end-to-end commercialization services to expedite and optimize targeting, access, adherence, and valued outcomes.
"These partnerships, along with the data we can capture across our comprehensive commercial services platform, will make a remarkable impact on the life sciences industry. It's so much more than integrating numbers and trendlines. It's about understanding what patients, providers and payers really need and how we can use our commercial platform to provide it. This will finally improve the healthcare system in a data-driven manner," said Jim Lang, CEO, EVERSANA.
EVERSANA and Symphony Health, a PRA Health Sciences company and a leading provider of data, cloud-based analytics, and consulting solutions to life science companies and healthcare organizations, finalized a multi-year relationship to provide access to real-time claims and electronic medical records data for more than 300 million patients. The data will be used to activate data-driven patient engagement and hub services to advance access and adherence at each stage of the product life cycle.
"At Symphony, our goal is to deliver data-driven insights that facilitate and transform the drug development process, bringing the right treatments to patients at the right time," said Doug Fulling, President, Symphony Health. "Our work with EVERSANA will deliver more actionable insights to the marketplace, allowing for increased data transparency, quicker access and a broader understanding of patient needs."
In addition to claims and EMR data, a partnership with Compile will further integrate physician data to drive market access and HCP engagement. By combining public, government, and deep-web data with privately licensed medical and pharmacy claims data, Compile generates the ultimate system of record on every practitioner, facility, health system, and event that takes place in the U.S. healthcare market. EVERSANA expects to announce a third partnership to integrate formulary data in the coming month.
The datasets from Symphony and Compile will feed into ACTICS by EVERSANA, a data-mastering platform, and cloud-based infrastructure. Through API-driven automated intelligence and machine learning technology, ACTICS provides downstream alerts and insights to additional cloud-based infrastructure, such as a client's CRM system, to create actionable insights.
ACTICS is being leveraged into the launch and commercialization strategies for multiple pharmaceutical and digital therapies and works seamlessly with EVERSANA's integrated commercial services platform designed to solve global pricing, access, reimbursement, real-world evidence, adherence, and product delivery challenges in the life sciences sector.